A Functional Promoter Haplotype of Macrophage Migration Inhibitory Factor Is Linked and Associated with Juvenile Idiopathic Arthritis

Arthritis and Rheumatism

Volumn 50, Issue 5, 2004, Pages 1604-1610

  Donn, Rachelle ^a   Alourfi, Zaynab ^a   Zeggini, Eleftheria ^a   Lamb, Rebecca ^a   Jury, Francine ^a   Lunt, Mark ^a   Meazza, Christina ^b   De Benedetti, Fabrizio ^c   Thomson, Wendy ^a   Ray, David ^a   Abinun, M ^d   Becker, M ^d   Bell, A ^d   Craft, A ^d   Crawley, E ^d   David, J ^d   Foster, H ^d   Gardener Medwin, J ^d   Griffin, J ^d   Hall, A ^d   Hall, M ^d   Herrick, A ^d   Hollingworth, P ^d   Holt, L ^d   Jones, S ^d   Pountain, G ^d   Ryder, C ^d   Southwood, T ^d   Stewart, I ^d   Venning, H ^d   Wedderbum, L ^d   Woo, P ^d   Wyatt, S ^d   more..

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d Stopford Building ^*

Author keywords

[No Author keywords available]

Indexed keywords

LUCIFERASE; MACROPHAGE MIGRATION INHIBITION FACTOR;

ALLELE; ARTICLE; DISEASE ASSOCIATION; EPITHELIUM CELL; GEL ELECTROPHORESIS; GENE INTERACTION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN CELL; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; T LYMPHOBLAST; UNITED KINGDOM;

ARTHRITIS, JUVENILE RHEUMATOID; C-REACTIVE PROTEIN; CELL LINE; GENES, REPORTER; HAPLOTYPES; HUMANS; LINKAGE (GENETICS); MACROPHAGE MIGRATION-INHIBITORY FACTORS; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); RESPIRATORY MUCOSA; T-LYMPHOCYTES; TRANSFECTION;

EID: 2342660658     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.20178     Document Type: Article

References (33)

1. Bloom BR, Bennett B. Relation of the migration inhibitory factor to delayed-type hypersensitivity reactions. Ann N Y Acad Sci 1970;169:258-65.
2. David JR. Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A 1966;56:72-7.
3. Lue H, Kleemann R, Calandra T, Roger T, Bernhagen J. Macrophage migration inhibitory factor: mechanisms of action and role in disease. Microbes Infect 2002;4:449-60.
4. Morand EF, Bucala R, Leech M. Macrophage migration inhibitory factor: an emerging therapeutic target in rheumatoid arthritis. Arthritis Rheum 2003;48:291-9.
5. Lolis E. Glucocorticoid counter regulation: macrophage migration inhibitory factor as a target for drug discovery. Curr Opin Pharmacol 2001;1:662-8.
6. Petty RE, Southwood TR, Baum J, Bhettay E, Glass DN, Manners P, et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. J Rheumatol 1998;25:1991-4.
7. Meazza C, Travaglino P, Pignatti P, Magni-Manzoni S, Ravelli A, Martini A, et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. Arthritis Rheum 2002; 46:232-7.
8. De Benedetti F, Meazza C, Vivarelli M, Rossi F, Pistorio A, Lamb R, et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2003; 48:1398-407.
9. Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, et al. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum 2002;46:2402-9.
10. Barton A, Lamb R, Symmons D, Silman A, Thomson W, Worthington J, et al. Macrophage migration inhibitory factor gene polymorphism is associated with susceptibility to but not severity of inflammatory polyarthritis. Genes Immun 2003;4:487-91.
11. Baugh JA, Chitnis S, Donnelly SC, Monteiro J, Lin X, Plant BJ, et al. A functional promoter polymorphism in the macrophage migration inhibitory factor gene associated with disease severity in rheumatoid arthritis. Genes Immun 2002;3:170-6.
12. Donn RP, Shelley E, Ollier WE, Thomson W. A novel 5′-flanking region polymorphism of macrophage migration inhibitory factor is associated with systemic-onset juvenile idiopathic arthritis. Arthritis Rheum 2001;44:1782-5.
13. Sham PC, Curtis D. An extended transmission/disequilibrium test (TDT) for multi-allele marker loci. Ann Hum Genet 1995;59: 323-36.
14. Zhaò JH, Curtis D, Sham PC. Model-free analysis and permutation tests for allelic associations. Hum Hered 2000;50:133-9.
15. Dudbridge F, Koeleman BP, Todd JA, Clayton DG. Unbiased application of the transmission/disequilibrium test to multilocus haplotypes. Am J Hum Genet 2000;66:2009-12.
16. Koeleman BP, Dudbridge F, Cordell HJ, Todd JA. Adaptation of the extended transmission/disequilibrium test to distinguish disease associations of multiple loci: the conditional extended transmission/disequilibrium test. Ann Hum Genet 2000;64:207-13.
17. Koeleman BP, Herr MH, Zavattari P, Dudbridge F, March R, Campbell D, et al. Conditional ETDT analysis of the human leukocyte antigen region in type 1 diabetes. Ann Hum Genet 2000;64:215-21.
18. Grom AA, Hirsch R. T-cell and T-cell receptor abnormalities in the immunopathogenesis of juvenile rheumatoid arthritis. Curr Opin Rheumatol 2000;12:420-4.
19. Adcock IM, Brown CR, Barnes PJ. Tumour necrosis factor α causes retention of activated glucocorticoid receptor within the cytoplasm of A549 cells. Biochem Biophys Res Commun 1996;225: 545-50.
20. Soden J, Stevens A, Ray DW. Genetic engineering of the glucocorticoid receptor by fusion with the herpes viral protein VP22 causes selective loss of transactivation. J Endocrinol 2002;172:615-25.
21. Stevens A, Garside H, Berry A, Waters C, White A, Ray D. Dissociation of steroid receptor coactivator 1 and nuclear receptor corepressor recruitment to the human glucocorticoid receptor by modification of the ligand-receptor interface: the role of tyrosine 735. Mol Endocrinol 2003;17:845-59.
22. Glass DN, Giannini EH. Juvenile rheumatoid arthritis as a complex genetic trait. Arthritis Rheum 1999;42:2261-8.
23. Thomson W, Donn R. Juvenile idiopathic arthritis genetics. What's new? What's next? Arthritis Res 2002;4:302-6.
24. Santos L, Hall P, Metz C, Bucala R, Morand EF. Role of macrophage migration inhibitory factor (MIF) in murine antigen-induced arthritis: interaction with glucocorticoids. Clin Exp Immunol 2001;123:309-14.
25. Leech M, Metz C, Santos L, Peng T, Holdsworth SR, Bucala R, et al. Involvement of macrophage migration inhibitory factor in the evolution of rat adjuvant arthritis. Arthritis Rheum 1998;41: 910-7.
26. Mikulowska A, Metz CN, Bucala R, Holmdahl R. Macrophage migration inhibitory factor is involved in the pathogenesis of collagen type II-induced arthritis in mice. J Immunol 1997;158: 5514-7.
27. Denkinger CM, Denkinger M, Kort JJ, Metz C, Forsthuber TG. In vivo blockade of macrophage migration inhibitory factor ameliorates acute experimental autoimmune encephalomyelitis by impairing the homing of encephalitogenic T cells to the central nervous system. J Immunol 2003;170:1274-82.
28. Lacey D, Sampey A, Mitchell R, Bucala R, Santos L, Leech M, et al. Control of fibroblast-like synoviocyte proliferation by macrophage migration inhibitory factor. Arthritis Rheum 2003;48:103-9.
29. De Jong YP, Abadia-Molina AC, Satoskar AR, Clarke K, Rietdijk ST, Faubion WA, et al. Development of chronic colitis is dependent on the cytokine MIF. Nat Immunol 2001;2:1061-6.
30. Nishihira J, Ogata A. Macrophage migration inhibitory factor as a target molecule in multiple sclerosis. Curr Opin Investig Drugs 2001;2:778-82.
31. Leech M, Metz C, Bucala R, Morand EF. Regulation of macrophage migration inhibitory factor by endogenous glucocorticoids in rat adjuvant-induced arthritis. Arthritis Rheum 2000;43: 827-33.
32. Sampey AV, Hall PH, Mitchell RA, Metz CN, Morand EF. Regulation of synoviocyte phospholipase A2 and cyclooxygenase 2 by macrvophage migration inhibitory factor. Arthritis Rheum 2001; 44:1273-80.
33. Gregersen PK, Bucala R. Macrophage migration inhibitory factor, macrophage migration inhibitory factor alleles, and the genetics of inflammatory disorders: incorporating disease outcome into the definition of phenotype. Arthritis Rheum 2003;48:1171-6.